We are live on ! Find out more
NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.23B
1-Year Est. Return 81.32%
This Fund
S&P 500
This Quarter Est. Return
-9.24%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$1.31B
AUM Growth
-$337M
Cap. Flow
-$134M
Cap. Flow %
-10.16%
Top 10 Hldgs %
74.12%
Holding
34
New
–
Increased
13
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
PCVX icon
Vaxcyte
PCVX
+$13.2M
2
CBLL
CeriBell Inc
CBLL
+$12.3M
3
CRNX icon
Crinetics Pharmaceuticals
CRNX
+$11.8M
4
EWTX icon
Edgewise Therapeutics
EWTX
+$9.18M
5
AVBP icon
ArriVent BioPharma
AVBP
+$8.6M

Top Sells

Rank Stock Value
1
TEM
Tempus AI
TEM
+$138M
2
BN icon
Brookfield
BN
+$26.5M
3
CRGX
CARGO Therapeutics
CRGX
+$24M
4
BABA icon
Alibaba
BABA
+$9.22M
5
CRM icon
Salesforce
CRM
+$6.56M

Sector Composition

Rank Sector Weight
1 Healthcare 50.89%
2 Technology 14.07%
3 Financials 9.29%
4 Consumer Discretionary 3.75%
5 Industrials 0.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNZA icon
26
LanzaTech
LNZA
$69.8M
$3.83M 0.29%
158,148
– –
IOBT
27
DELISTED
IO Biotech
IOBT
$3.66M 0.28%
3,354,449
– –
KYTX icon
28
Kyverna Therapeutics
KYTX
$484M
$3.57M 0.27%
1,850,000
– –
ABCL icon
29
AbCellera Biologics
ABCL
$2.12B
$2.51M 0.19%
1,126,915
– –
MQ icon
30
Marqeta
MQ
$1.66B
$1.82M 0.14%
110,390
– –
DMRA
31
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.84B
$310K 0.02%
99,913
– –
CRGX
32
DELISTED
CARGO Therapeutics
CRGX
– –
-1,663,724
Closed -$24M
MRSN
33
DELISTED
Mersana Therapeutics
MRSN
– –
-170,000
Closed -$6.08M
TEM
34
Tempus AI
TEM
$9.39B
– –
-4,074,419
Closed -$138M
1
2

Similar funds

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return
HTHT
Hemenway Trust Hemenway Trust Salem, New Hampshire $1.24B AUM 16.52% 1-Year Est. Return
BCP
BlackBarn Capital Partners New York $1.24B AUM 55.98% 1-Year Est. Return
SPC
Stony Point Capital New York $1.24B AUM 32.69% 1-Year Est. Return
SC
Strategy Capital Los Altos, California $1.22B AUM 27.02% 1-Year Est. Return

Novo Holdings A/S's Q1 2025 Portfolio in Review

As of Q1 2025, Novo Holdings A/S held 34 positions worth $1.31B, down 20% from $1.65B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Novo Holdings A/S withdrew a net $134M in Q1 2025, closing 3 positions and reducing 4 holdings. Its most notable exit was Tempus AI, an estimated $138M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 55% a quarter earlier, followed by Technology and Financials.

Against the trend, Novo Holdings A/S added an estimated $13.2M to Vaxcyte.

  • Novo Holdings A/S added most to Vaxcyte in Q1 2025, an estimated $13.2M increase.
  • Novo Holdings A/S's biggest Q1 2025 reduction was Brookfield, cutting an estimated $26.5M.
  • Novo Holdings A/S fully exited Tempus AI in Q1 2025, selling an estimated $138M.
  • Novo Holdings A/S's ten largest holdings make up 74% of its $1.31B portfolio in Q1 2025.
  • Novo Holdings A/S opened 0 new positions and closed 3 in Q1 2025.
  • Novo Holdings A/S's portfolio value fell 20% quarter-over-quarter to $1.31B.

Based on Novo Holdings A/S's 13F filing for Q1 2025, filed 15 May 2025.